Semaglutide Shelf Life & Storage: Clinical Guidelines

Last reviewed: June 1, 2026

Last updated: June 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide remains stable for 36 months when unopened and stored at 2-8°C (36-46°F), or up to 28 days at room temperature after first use. This timeline varies slightly depending on formulation type—injection versus oral—and storage conditions, making proper refrigeration and handling essential for maintaining medication efficacy.

Understanding semaglutide's stability window matters beyond convenience. For patients pursuing precision wellness with compounded formulations, storage integrity directly impacts clinical outcomes. PlexusDx emphasizes that proper storage protocols, combined with biomarker context about individual GLP-1 receptor responsiveness, help ensure optimal results and cost-effective therapy throughout your treatment course.

Semaglutide Stability Timeline: From Pharmacy to Injection

Semaglutide injections maintain pharmaceutical stability for 36 months from the manufacturing date when stored unopened in a refrigerator between 2-8°C. Once you initiate treatment and open a pen or vial, the medication begins degrading. Compounded semaglutide follows similar stability guidelines established by USP and state pharmacy boards, though specific timelines depend on the compounding pharmacy's validation studies.

After opening, semaglutide remains usable for 28 days if refrigerated continuously. If exposed to room temperature (up to 30°C or 86°F) for brief periods during transport or use, it may remain safe for several hours, but prolonged room-temperature storage compromises efficacy. Always document the date you first used your semaglutide to avoid accidental expiration.

Storage Protocol Comparison: Refrigerated vs. Room Temperature Settings

Proper storage extends semaglutide's usable life and prevents costly waste. The conditions below outline how different storage environments affect stability and when you should discard unused medication.

Refrigerated storage is the gold standard for both branded and compounded semaglutide formulations. Room-temperature exposure should be temporary and carefully tracked to avoid compromising medication quality and your clinical outcomes.

Storage Condition	Semaglutide Duration	Temperature Range	Safety Notes
Unopened in refrigerator	36 months from manufacture date	2-8°C (36-46°F)	Check expiration date before use
Opened vial/pen in refrigerator	28 days after first use	2-8°C (36-46°F)	Document opening date clearly
Temporary room temperature (transport)	Up to several hours	Below 30°C (86°F)	Avoid repeated heat exposure
Exposed to freezing or heat damage	Discard immediately	Below 0°C or above 30°C	Do not use if frozen or overheated

Biomarkers That Influence How Long Semaglutide Effects Last in Your Body

While pharmaceutical shelf life addresses medication chemistry, how long semaglutide's *clinical effects* persist depends partly on individual biomarkers. GLP-1 receptor expression, genetic variations in the GLP1R gene, and metabolic markers like fasting glucose and insulin sensitivity influence how your body responds to and sustains the medication's therapeutic window.

Patients with specific variants in metabolic genes (such as FTO rs9939609 or MC4R rs17782313) may experience different durations of appetite suppression or weight-loss plateaus. Understanding your biomarker profile through genetic testing can help your provider adjust dosing intervals or treatment duration more precisely, optimizing both medication stability management and clinical outcomes.

Safety Considerations: Recognizing When to Replace or Discard Semaglutide

Never use semaglutide past its expiration date or after 28 days of opening. Expired or compromised medication may not deliver consistent dosing, increasing the risk of suboptimal glucose control or unpredictable side effects. Visual inspection is important: discard the vial or pen if the solution appears cloudy, discolored, or contains particles—signs of bacterial growth or chemical degradation.

Compounded semaglutide must follow the same stringent storage and expiration protocols as branded formulations. Work closely with your compounding pharmacy and healthcare provider to establish a medication management routine. If you cannot complete a vial within 28 days, discuss extended-interval dosing or lower starting doses with your provider to minimize waste while maintaining safety and efficacy.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context about your genetic predispositions in GLP-1 signaling pathways. Variants in GLP1R rs6923761 and GIPR rs1800437 can influence how efficiently your body processes and responds to semaglutide over time. This biomarker insight, interpreted with a qualified healthcare provider, supports more personalized dosing strategies and storage management tailored to your metabolism.

The Precision Peptide Genetic Test reveals predispositions in peptide genetic pathways—not exact medication response. Understanding your FTO rs9939609, MC4R rs17782313, and GLP1R variants does not predict guaranteed outcomes, but it can support a more informed conversation with your provider about whether standard dosing intervals align with your biological profile or whether adjusted protocols may optimize results.

When you combine pharmacological knowledge (medication stability and storage) with genetic context (your GLP-1 pathway predispositions), you gain a more complete picture for treatment planning. This dual approach helps ensure that the semaglutide you're storing safely in your refrigerator will perform optimally once injected, aligned with your individual biomarker profile and treatment goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $229-$509/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.